Search - tctmd.com

Displaying 201 - 220 of 221

Sort: Relevancy | Date

Presentation CACI 2019

TAVI in Low Risk Patients

Presenter: Fayaz Shawl

November 29, 2019

Presentation CACI 2019

¿Es posible tratar bajo riesgo en Argentina?

Presenter: Daniel Berrocal

November 29, 2019

Presentation CACI 2019

Evaluación de riesgo en la selección del paciente para TAVR

Presenter: Pablo Stutzbach

November 29, 2019

Presentation CACI 2019

Consenso TAVI 2

Presenter: Carla Agatiello

November 29, 2019

Presentation Controversies and Advances 2019

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Presenter: Raj R. Makkar

November 15, 2019

Presentation Controversies and Advances 2019

CCTA/ FFRct for complex CAD

Presenter: Jonathon Leipsic

November 15, 2019

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation

TAVR SESSION: Pure Aortic Regurgitation

Presenter: Damiano Regazzoli

February 12, 0020

CME

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

Video

» Topical Discussion

Structural Heart Clinical Takeaways from TCT 2020

November 18, 2020

Video

» Interview

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

October 16, 2020

Video

» Topical Discussion

Restructuring Structural Heart Practice During COVID-19

April 21, 2020

Partner Content

Registration - Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

October 26, 2020

Video

» Interview

REFLECT II: A Randomized Trial of a Cerebral Embolic Protection Device During TAVR

October 15, 2020

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Video

» Live Case

Live Case: Quebec Heart & Lung Institute, Laval University; STRUCTURAL - TAVR (SAPIEN 3 Ultra) for AS With a Small Annulus

October 6, 2020

Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

CME

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

Partner Content

Evolut™ Implant Strategies

December 30, 2020

Advertisement

TAVI in Low Risk Patients

¿Es posible tratar bajo riesgo en Argentina?

Evaluación de riesgo en la selección del paciente para TAVR

Consenso TAVI 2

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

CCTA/ FFRct for complex CAD

Show me the Data: Key Clinical Trials of 2019

TAVR SESSION: Pure Aortic Regurgitation

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

Structural Heart Clinical Takeaways from TCT 2020

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

Restructuring Structural Heart Practice During COVID-19

Registration - Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

REFLECT II: A Randomized Trial of a Cerebral Embolic Protection Device During TAVR

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Live Case: Quebec Heart & Lung Institute, Laval University; STRUCTURAL - TAVR (SAPIEN 3 Ultra) for AS With a Small Annulus

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

Evolut™ Implant Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content